CAPRICOR THERAPEUTICS INC. - COMMON STOCK
5.3400
08-May-24 12:43:51
15 minutes delayed
Stocks
-0.1200
-2.20%
Today's range
5.2500 - 5.4770
ISIN
N/A
Source
NASDAQ
-
08 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
02 Mar 2023 08:15:00 By Nasdaq GlobeNewswire
-
16 Feb 2023 08:25:00 By Nasdaq GlobeNewswire
-
25 Jan 2023 07:00:00 By Nasdaq GlobeNewswire
-
19 Jan 2023 15:05:00 By Nasdaq GlobeNewswire
-
Capricor Announces Publication Highlighting New Advances for its Engineered Exosome Platform
12 Jan 2023 08:26:27 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
10 Nov 2022 15:01:00 By Nasdaq GlobeNewswire
-
03 Nov 2022 15:01:00 By Nasdaq GlobeNewswire
-
06 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Capricor Therapeutics to Present at Upcoming Investor Conferences
07 Sep 2022 07:00:02 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
10 Aug 2022 15:05:00 By Nasdaq GlobeNewswire
-
03 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
19 Jul 2022 08:15:00 By Nasdaq GlobeNewswire
-
17 Jun 2022 08:00:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Appoints Xavier Avat as Chief Business Officer
25 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
Capricor Therapeutics to Present at the H.C. Wainwright Global Investment Conference
18 May 2022 08:00:01 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
10 May 2022 15:01:00 By Nasdaq GlobeNewswire
-
03 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics to Participate in the Cantor Fitzgerald Rare Orphan Disease Summit
29 Mar 2022 08:00:01 By Nasdaq GlobeNewswire